21.2 C
New York
Thursday, June 18, 2026

Tag: methodology

newssourceFORcompanyinformationcontent1marketreleases

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund Investors...

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of shares of the Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund (the “Fund”) (tickers: RMJAX, RMHVX, RMHIX), between May 5, 2023 and June 12, 2025, inclusive (the “Class Period”). The Fund is a mutual fund within defendant James Alpha Funds Trust’s series of mutual funds (which does business as Easterly Funds Trust). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2025.

Athabasca Oil Announces 2025 Second Quarter Results Highlighted by Strong Operational Results, Continued Share Buybacks and a Pristine Financial Position

CALGARY, Alberta, July 24, 2025 (GLOBE NEWSWIRE) -- Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to report its second quarter results marked by strong operational performance, consistent financial results and execution on return of capital commitments. With low corporate break-evens, differentiated long-life assets and a pristine balance sheet, the Company is well positioned to advance its strategic priorities.

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

Automotive IDM Market Size to Grow USD 14450 Million by 2031 at a CAGR of 11.9% | Valuates Reports

BANGALORE, India, July 24, 2025 /PRNewswire/ -- Automotive IDM Market is Segmented by Type (Advanced Packaging, Mainstream Packaging), by Application (Leadframe, MEMS & Sensors,...

Edf: 2025 half-year results – Operational performance in line with expectations – Positive cash flow in a context of falling market prices and rising...

2025 half-year results

SHEIN Unveils Summer of Sport: Up to 50% Off Activewear and a Spotlight on Its Expanding Activewear Category

SHEIN is kicking off the season with its first Summer of Sport campaign, helping Canadians stay active and stylish with performance-driven pieces

Orange Belgium announces a new Management Services Agreement with Orange SA

Press release
Brussels, 24 July 2025
 Regulated information – Inside information

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Ribbon Communications Inc. Reports Second Quarter 2025 Financial Results

Record Second Quarter Revenue Up 15% Year Over Year Profitability at High End of Guidance Robust Growth in Service Provider and Enterprise Markets PLANO, Texas, July...

Hydrasphere Plus Launches Comprehensive Skincare System Targeting Texture, Muscle Tone, and Collagen Renewal

Boca Raton, FL, July 23, 2025 (GLOBE NEWSWIRE) -- Hydrasphere Plus, a Florida-based skincare innovator, has officially launched a pioneering three-pillar system designed to transform the science of facial health. Built on decades of dermatological research and cosmetic formulation expertise, the new Hydrasphere Plus system uniquely targets skin texture, facial muscle tone, and collagen production—three biological pillars essential to long-term skin vitality.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMethodology

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers